Abstract
BackgroundThe binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response. The identification of such peptide epitopes has potential applications in vaccine design and in better understanding autoimmune diseases and allergies. However, comprehensive experimental determination of peptide-MHC binding affinities is infeasible due to MHC diversity and the large number of possible peptide sequences. Computational methods trained on the limited experimental binding data can address this challenge. We present the MultiRTA method, an extension of our previous single-type RTA prediction method, which allows the prediction of peptide binding affinities for multiple MHC allotypes not used to train the model. Thus predictions can be made for many MHC allotypes for which experimental binding data is unavailable.ResultsWe fit MultiRTA models for both HLA-DR and HLA-DP using large experimental binding data sets. The performance in predicting binding affinities for novel MHC allotypes, not in the training set, was tested in two different ways. First, we performed leave-one-allele-out cross-validation, in which predictions are made for one allotype using a model fit to binding data for the remaining MHC allotypes. Comparison of the HLA-DR results with those of two other prediction methods applied to the same data sets showed that MultiRTA achieved performance comparable to NetMHCIIpan and better than the earlier TEPITOPE method. We also directly tested model transferability by making leave-one-allele-out predictions for additional experimentally characterized sets of overlapping peptide epitopes binding to multiple MHC allotypes. In addition, we determined the applicability of prediction methods like MultiRTA to other MHC allotypes by examining the degree of MHC variation accounted for in the training set. An examination of predictions for the promiscuous binding CLIP peptide revealed variations in binding affinity among alleles as well as potentially distinct binding registers for HLA-DR and HLA-DP. Finally, we analyzed the optimal MultiRTA parameters to discover the most important peptide residues for promiscuous and allele-specific binding to HLA-DR and HLA-DP allotypes.ConclusionsThe MultiRTA method yields competitive performance but with a significantly simpler and physically interpretable model compared with previous prediction methods. A MultiRTA prediction webserver is available at http://bordnerlab.org/MultiRTA.
Highlights
The binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response
MultiRTA models for both HLA-DR and HLA-DP are fit and their performance evaluated by leave-oneallele-out cross-validation, in which predictions are made for one allotype using a model fit to experimental binding data for the remaining MHC allotypes in the data set
The results for MultiRTA and NetMHCIIpan were obtained using leave-one-allele-out cross-validation, in which predictions are made for one allotype using a model trained on the data for the remaining allotypes
Summary
The binding of peptide fragments of antigens to class II MHC is a crucial step in initiating a helper T cell immune response The identification of such peptide epitopes has potential applications in vaccine design and in better understanding autoimmune diseases and allergies. Promiscuous class II MHC peptide epitopes, which bind to diverse MHC allotypes, can be employed in vaccines that are efficacious for a large proportion of the population [15,16,17,18]. In spite of their medical importance, the peptide binding preferences of different class II MHC proteins have not been fully characterized by experiments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.